Johnson & Johnson's LifeScan gets FDA warning for QS violations
This article was originally published in Clinica
Executive Summary
LifeScan is once again in trouble with the US FDA. The company received an FDA warning letter on December 7 for quality systems violations identified during an April 6-June 30 inspection of its plant in Milpitas, California, where the One Touch Ultra blood glucose monitor is manufactured.